Targeting LDL Cholesterol: Beyond Absolute Goals Toward Personalized Risk

Area of Science:

• Cardiovascular Medicine
• Preventive Cardiology
• Lipid Metabolism

Background:

• Current guidelines for cardiovascular disease (CVD) prevention rely on low-density lipoprotein cholesterol (LDL-C) treatment goals.
• Primary prevention often uses population-based risk models, while secondary prevention focuses on specific LDL-C targets or percentage reductions.

Purpose of the Study:

• To review and assess the evidence supporting current LDL-C treatment goals for primary and secondary CVD prevention.
• To evaluate the effectiveness of existing risk models and treatment targets.

Main Methods:

• Systematic review of current guidelines and clinical studies.
• Analysis of population-based risk models for primary prevention.
• Evaluation of clinical trial data for secondary prevention.

Main Results:

• Population-based risk models for primary prevention show moderate discrimination but poor calibration and risk overestimation.
• Clinical trial data are not compelling to support specific LDL-C targets or percentage reductions in secondary prevention.
• Existing guidelines may not be optimally evidence-based.

Conclusions:

• There is a need to re-evaluate current LDL-C treatment goals based on available evidence.
• The development of individualized treatment goals is crucial for optimizing CVD prevention.
• Leveraging electronic health records and data analytics can facilitate personalized treatment strategies.